A
Market Data
$79.24−$3.54 (−4.28%)
ANIP · Last trade
Prev Close
$82.78
Range (30d)
$77.61 – $86.03
Recent Filings
- 1447.4 KBANI PHARMACEUTICALS INCJul 29, 4:21 PM ET·0001950047-26-007411
- SCHEDULE 13G/A11.3 KBANI PHARMACEUTICALS INCJul 27, 4:25 PM ET·0002012383-26-002156
- 8-K309.8 KBANI PHARMACEUTICALS INCMay 21, 4:13 PM ET·0001023024-26-000056
- 8-K4.6 MBANI PHARMACEUTICALS INCMay 13, 8:27 AM ET·0001023024-26-000054
- 10-Q8.7 MBANI PHARMACEUTICALS INCMay 8, 6:58 AM ET·0001023024-26-000050
- 8-K424.7 KBANI PHARMACEUTICALS INCMay 8, 6:56 AM ET·0001023024-26-000049
- 8-K182.2 KBANI PHARMACEUTICALS INCApr 7, 4:21 PM ET·0001023024-26-000034
- 8-K4.6 MBANI PHARMACEUTICALS INCMar 3, 7:05 AM ET·0001023024-26-000017
- 10-K17.0 MBANI PHARMACEUTICALS INCFeb 27, 6:59 AM ET·0001023024-26-000014
- 8-K575.9 KBANI PHARMACEUTICALS INCFeb 27, 6:57 AM ET·0001023024-26-000013
Insiders
10- BELL STEVEN JVP Research & Pre-Clinical Dev
- Brown Robert E. JR10% Owner
- CAREY STEPHEN P.SVP & CFO
- Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
- Davis KristaSVP, CHIEF HR OFFICER
- Donenberg Phillip B.Sr VP of Finance, CFO, Secy
- EDELMAN JOSEPH10% Owner
- Gassert ChadSVP - CORP. DEV. & STRATEGY
- Gutwerg OriSVP, GENERICS
- HAUGHEY THOMASDirector
Tickers
Addresses
business
104 CARNEGIE CENTER DRIVE SUITE 300
PRINCETON, NJ, 08540
mailing
104 CARNEGIE CENTER DRIVE SUITE 300
PRINCETON, NJ, 08540
Former Names
- BIOSANTE PHARMACEUTICALS INC2013-07-18
- BEN ABRAHAM TECHNOLOGIES INC1999-12-23